retatrutide triple agonist glp-1 gip glucagon receptor Demonstrated metabolic effects of GIP, and GCG agonism as mono, What GLP‑3 Really Is: Retatrutide
Description
Sikirica, M
doi: 10.1007/s12020-020-02223-6 12 BrownJCDryburghJRRossSADuprJ
Lillys pursuit of small-molecule GLP-1s like orforglipron indicates a strategic move to fully chemical manufacturing, which if successful could shift manufacturing out of peptide processes entirely
Lifetime and annual dollar limits are permitted currently on drugs that are not essential health benefits under the ACA, but the ability to apply these limits faces an uncertain future and should be monitored closely
